A recently described bacterium, Alcaligenes piechaudii, was isolated repeatedly from the ear discharge of a diabetic man. This appears to be the first report of human infection in which there is clinical evidence of a pathogenic role for this species.
positive, gram-negative rods were cultured from specimens taken at all six presentations, usually with coagulase-negative staphylococci but once as a profuse growth in pure culture.
The isolate grew as a strict aerobe on horse blood agar, MacConkey agar (CM7b), and nutrient agar (Oxoid) after incubation at 37°C for 24 h. Colonies were nonhemolytic. The bacilli were motile at 22 and 37°C. Flagellar arrangement was shown to be peritrichous by electron microscopy. Physiological tests were performed by conventional methods (1, 5) and included the ability to grow in a basal medium containing P-hydroxybutyrate as sole carbon source (9).
Acid production from carbohydrates was tested in an ammonium salt basal medium (8) . The results are listed in Table   1 .
A comparative disk method (10) was used for testing antimicrobial susceptibility to Framycetin (100 ,ug), neomycin (30 ,ug), and polymyxin B (300 IU). Susceptibility to other antimicrobial agents was tested by using the Dynatech MIC 2000 System (Dynatech Laboratories, Inc., Alexandria, Va.) with a modified broth dilution technique (4) . The isolate was susceptible to amoxycillin and polymyxin B, of inter- Four of the seven strains which were initially characterized as A. piechaudii were isolated from human clinical specimens, one was from soil, and two were of unknown origin (2) . Few clinical details were available on the human isolates. The name A. piechaudii had been suggested earlier for one of the clinical isolates, the so-called Alcaligenes faecalis CIP-6075, which was shown to be phenotypically and genetically distinct from A. faecalis and other species of Alcaligenes (3). The specific epithet was chosen to honor the French bacteriologist Michel Piéchaud.
Our isolate of A. piechaudii was cultured repeatedly from chronic ear discharge in a diabetic man. None of the four original isolates of A. piechaudii of human origin was associated with otitis (2), but other species of the genus Alcaligenes were reported previously from ear discharges (7) . The original description of Alcaligenes xylosoxidans subsp. xylosoxidans (2) (then Achromobacter xylosoxidans) was based on a study of seven strains, all of which were isolated from purulent ear discharges in patients with chronic otitis media (11) . Indeed, it has been suggested on the basis of the isolation of this species in mixed cultures from five of nine patients with purulent ear discharge that some of the "Pseudomonas sp." reported in otitis externa may actually be A. xylosoxidans subsp. xylosoxidans (6) . Species in the genus Alcaligenes are generally regarded as being opportunistic pathogens (7), and it is likely that the diabetic condition of the patient predisposed him to infection by A. piechaudii. This is supported by the association of a definite improvement with stabilization of the patient's diabetes.
The key characteristics of A. piechaudii are as follows. It is a gram-negative rod, motile by peritrichous flagella, aerobic, catalase positive, and oxidase positive. It has an alkaline reaction in Hugh and Leifson medium, is nonsaccharolytic, and reduces nitrate but not nitrite. A. piechaudii may not yet be familiar to many laboratory workers, but it has been encountered in clinical material and may play a pathogenic role, as this case illustrates.
